Skip to main content
ACS AuthorChoice logoLink to ACS AuthorChoice
. 2021 Jun 22;86(13):9181–9188. doi: 10.1021/acs.joc.1c00413

A Concise Route to Water-Soluble 2,6-Disubstituted BODIPY-Carbohydrate Fluorophores by Direct Ferrier-Type C-Glycosylation

Ana M Gómez †,*, Clara Uriel , Ainhoa Oliden-Sánchez , Jorge Bañuelos ‡,*, Inmaculada Garcia-Moreno §, J Cristobal López †,*
PMCID: PMC8279486  PMID: 34156858

Abstract

graphic file with name jo1c00413_0007.jpg

Novel, linker-free, BODIPY-carbohydrate derivatives containing sugar residues at positions C2 and C6 are efficiently obtained by, hitherto unreported, Ferrier-type C-glycosylation of 8-aryl-1,3,5,7-tetramethyl BODIPYs with commercially available tri-O-acetyl-d-glucal followed by saponification. This transformation, which involves the electrophilic aromatic substitution (SEAr) of the dipyrrin framework with an allylic oxocarbenium ion, provides easy access to BODIPY-carbohydrate hybrids with excellent photophysical properties and a weaker tendency to aggregate in concentrated water solutions.


The burgeoning interest in fluorescence imaging techniques as non-invasive, highly sensitive, and operationally simple ways to visualize biological processes has spurred the development of biocompatible, water-soluble fluorophores.1 In this context, the consideration of boron dipyrromethene difluoride (BODIPY) dyes, e.g., 1 (Figure 1), has amply surpassed that of the traditionally studied fluorescein, cyanine, and rhodamine fluorophores.2 Thus, among other fluorophores, BODIPYs excel in their remarkable properties, including strong absorption, high molar absorption coefficients and fluorescence quantum yields, good chemical and photochemical stability, and low toxicity.3 Nevertheless, arguably, their main appeal might be their ability to fine-tune their spectroscopic and photophysical properties by postfunctional modifications of the dipyrromethene core.4

Figure 1.

Figure 1

BODIPY (1, IUPAC numbering), BODIPY equipped for solubilization in water (2), and water-soluble, linker-free, 2,6-substituted glyco-BODIPYs (3).

In this context, a variety of postfunctionalization studies have emerged to improve water solubility and minimize aggregation-induced quenching of BODIPY fluorophores.5 These studies have involved the peripheral incorporation of charged anionic, cationic, and zwitterionic functionalities, the grafting of the BODIPY to neutral hydrophilic compounds, or combinations thereof, e.g., 2 (Figure 1).68 On the contrary, the introduction of bulky substituents into the fluorophore core, or at the apical position, has been used to prevent aggregation, a phenomenon known to lower the quantum yield of fluorophores.9

Among the neutral hydrophilic derivatives employed for solubilization of BODIPYs, carbohydrates have received more consideration. This attention is, very likely, motivated by the fact that carbohydrates, in addition to water solubility, might provide biocompatibility and enhanced targeting ability to the ensuing glyco-BODIPYs.10

In general, carbohydrates have been incorporated into the periphery of the BODIPY core, frequently by being attached to alkyl or aryl substituents located at the meso (C8) position,11 or at the boron atom,12 normally through a linker, in transformations that generally involve copper(I)-catalyzed azide–alkyne cycloadditions (CuAAC).13 On the contrary, scarce examples of O-glycosylation reactions, the most common being the glycosyl coupling method,14 have been reported for the assembly of carbohydrates with BODIPYs.15

According to these precedents, we envisioned that it would be of interest to develop a C-glycosylation protocol16 that could engage positions C2 and C6 of the BODIPY core, in commonly used 1,3,5,7-tetramethyl BODIPYs. Such a method could provide direct access to “linker-free”, nonhydrolyzable, water-soluble bis-C-glycosidic BODIPYs, e.g., 3 (Figure 1).

Thus, even though positions C2 and C6 of the boraindacene core are prone to experiencing electrophilic aromatic substitution (SEAr) reactions,4 to the best of our knowledge, no C-glycosylation reaction has been reported to date. In this context, we had already observed the reluctance of the BODIPY core to undergo such a reaction in glycosylations of hydroxyl-containing BODIPYs with common glycosyl donors, where no sign of C-glycosylation adducts had been detected.15b,15d Furthermore, in the course of this work, the attempted reaction of 8-aryl-1,3,5,7-tetramethyl BODIPYs with glycosyl trichloroacetimidate donors failed to provide any C-glycosylated BODIPYs. We, therefore, reasoned that compared to a classical glycosyl oxonium ion, e.g., 4 (Figure 2), arising from a standard glycosyl donor, a more stabilized and less sterically encumbered, allylic oxocarbenium ion, i.e., 5 (Figure 2),17,18 might be able to glycosylate the 4-bora-3a,4a-diaza-s-indacene skeleton. Under such premises, we decided to test the electrophilic Ferrier-type C-glycosylation reaction (which involves allylic cation 5) of 8-aryl and 8-methyl 1,3,5,7-tetramethyl BODIPYs 6 and 7, respectively (Figure 2).

Figure 2.

Figure 2

Glycosyl cation (4), allylic glycosyl cation (5), and 8-(meso)-substituted 1,3,5,7-tetramethyl BODIPYs 6a–c and 7.

Ferrier-type glycosylations involve the treatment of Δ1,2-unsaturated monosaccharides, 1,5-anhydrohex-1-enitols, commonly termed glycals, e.g., 8 (Scheme 1), with a Lewis acid to generate reactive electrophilic species 5.17,18 Accordingly, we tested the reaction of meso-phenyl BODIPY 6a with commercially available tri-O-acetyl-d-glucal (3,4,6-tri-O-acetyl-1,5-anhydro-2-deoxy-d-arabino-hex-1-enitol) 8 in the presence of three different Lewis acids, BF3·OEt2, InCl3, and Yb(OTf)3. The best results were observed when 8 (3.0 equiv) and BODIPY 6a were treated with BF3·OEt2 (0.15 equiv) at −20 °C in dichloromethane. Under these conditions, bis-β-BODIPY-C-glycoside 9 was obtained as the sole isomer in 68% yield (Scheme 1a). Remarkably, the incorporation of the two glycosyl units at C2 and C6 of the BODIPY core in 9 had taken place in a completely regioselective (C1′ rather than C3′) and stereoselective manner (vide infra)19,20 with regard to the carbohydrate moiety (Scheme 1a). Likewise, glycosylation of 8-o-azidomethyl phenyl BODIPY 6b with d-glucal 8 (4.0 equiv) provided compound 11, again as a single regio- and stereoisomer, in 70% yield (Scheme 1b). Next, the reaction of 8-o-hydroxymethyl phenyl BODIPY 6c, containing an additional hydroxyl site for glycosylation, with glycal 8 (5.0 equiv) provided tris-glycosyl BODIPY 12 as a single α,β,β stereoisomer (the O-glycosylation at the meso o-hydroxymethyl substituent was ascribed as α, according to well-established literature precedents on the Ferrier glycosylation of alcohols)17 in 72% yield (Scheme 1c). Conversely, the attempted glycosylation of pentamethyl BODIPY 7, under similar reaction conditions, led only to extensive decomposition of the fluorophore.

Scheme 1. Ferrier-Type Glycosylation of BODIPYs 6a–c with Tri-O-acetyl-d-glucal 8.

Scheme 1

The β configuration at the anomeric center (C1′ or C1″) on each hex-2-eno-pyranoside moieties in compound 9 was rigorously established by hydrogenation to corresponding saturated derivative 10 (Figure 3), whose 1H NMR analysis allowed us to assess the axial orientation of the carbohydrate H1′ and H1″ protons.21 Saponification of the acyl groups in BODIPY-saccharides 9, 11, and 12 was performed by treatment with Et3N/MeOH (1:4) and led to water-soluble tetraols 13a and 13b and hexaol 14, respectively (Figure 3).

Figure 3.

Figure 3

Glyco-BODIPYs 10, 13a, 13b, and 14.

Azidomethyl BODIPY 6b was selected in this study because the ensuing C-glycosyl BODIPYs 11 and 13b possess an additional site (N3) for conjugation.11c,15b,22 One example of the versatility of these compounds was provided by the one-pot dimerization of 11 and 13b, leading to bis-urea derivatives 15 and 16, respectively (Figure 4).22

Figure 4.

Figure 4

Bis-BODIPY ureas 15 and 16, obtained by dimerization of 11 and 13b, respectively [Et3NHCO3 (TEAB) (4.0 equiv), PPh3 (1.5 equiv)].

The photophysical behavior of the new glyco-BODIPYs was evaluated under both soft and laser irradiation. The small-molecule BODIPY-C-glycosides (acetylated 9, 11, and 12 and saponified 13a, 13b, and 14) displayed strong absorption and fluorescence bands centered around 510 and 520 nm, respectively, showing the low negative solvatochromism distinctive of these fluorophores (Figure S1).15b The conformationally restricted molecular geometry of the new glyco-dyes led to an efficient fluorescence emission with quantum yields ranging from 50% to 90% and monoexponential lifetimes ranging from 3 to 5 ns (Figure 5 and Table 1). The theoretical simulation of the optimized molecular geometries of the glyco-BODIPYs confirmed that the persubstitution of the dipyrrin system exerted the desired sterical hindrance at the 2,6-saccharides and, especially, at the 8-aryl moiety, placing all of these rings orthogonal to the chromophoric core (Figure S2). In this way, nonradiative deactivation funnels related to the free motion of the substituents were at least partially hindered, because further structural constraints still ameliorated the fluorescence response (Table 1). In fact, the 8-aryl moiety in 9 and 13a, despite the 1,7-methylation of the dipyrrin, could retain some rotational freedom around its perpendicular disposition, decreasing the fluorescence efficiency to 50%. Further sterical hindrance asserted by ortho substitution at this 8-aryl moiety completely locked its slight rotational motion, fixing its structural disposition.23 This structural arrangement entailed a more efficient fluorescence response (≤90%) owing to a decrease in the nonradiative rate constant (Figure 5 and Table S1). Although overall the photophysical signatures of the acetylated and hydroxyl-free glyco-BODIPYs are quite similar (Table 1 and Table S1), decreases in both the absorption and the fluorescence probability are found upon deprotection of the carbohydrate moieties. The absorption spectral profile of the unprotected glyco-BODIPYs becomes slightly flattened and broadened [full width at half-maximum (fwhm) increase around 100 cm–1], leading to a decrease in the molar absorption coefficient that runs simulatenously with a less pronounced decrease in the corresponding oscillator strength [calculated from the area under the absorption band (see Table 1 and Table S1)].

Figure 5.

Figure 5

Variation of the fluorescence efficiency with the solvent (EtOAc, CH3CN, and H2O) for BODIPYs 13a, 13b, and 14 and bis-BODIPY 16, all grafted to unprotected sugar units. Representative absorption and fluorescence spectra are also included.

Table 1. Photophysical Properties of Glyco-BODIPYs with Protected (9, 11, 12, and 15, in ethyl acetate) and Unprotected (13a, 13b, 14, and 16, in water) Carbohydrate Moieties (dye concentration of 2 μM)a.

  λab (nm) εmax (f) (×104 M–1 cm–1) λfl (nm) ϕ τ (ns)
9 509.0 10.4 (0.57) 521.0 0.66 3.68
11 512.5 8.8 (0.48) 525.0 0.91 4.93
12 511.5 10.9 (0.58) 522.5 0.88 5.06
15 510.0 14.9 (0.71) 523.5 0.59 4.72b
13a 504.5 3.5 (0.30) 517.0 0.47 3.42
13b 509.0 5.6 (0.40) 521.5 0.67 5.14
14 508.0 5.9 (0.40) 521.0 0.77 5.26
16 507.5 8.0 (0.50) 522.0 0.08 3.81b
a

Full photophysical data for the saponified compounds are listed in Table S1 for the single BODIPYs and Table S3 for the bis-BODIPYs. Absorption (λab) and fluorescence (λfl) wavelengths, molar absorption coefficients at the maximum (εmax), oscillator strengths (f), fluorescence quantum yields (ϕ), and lifetimes (τ) are given. Estimate errors: ±0.5 nm for wavelengths and 5% for the rest of the parameters.

b

Amplitude average lifetime of the resulting biexponential fit of the decay curves (Table S3).

BODIPYs grafted to unprotected sugar units (13a, 13b, and 14) were completely soluble in water in the millimolar range at room temperature (Figure S3) and retained a noticeable fluorescence efficiency [i.e., ≤77% for 14 (Figure 5 and Table 1)]. Increasing the dye concentration in water altered neither the absorption nor the fluorescence profiles, highlighting the absence of intermolecular aggregation, the most effective deactivation pathway of BODIPY in water, which is unambiguously tracked through the drastic changes induced in the spectral bands.9c Therefore, these glyco-BODIPYs are not prone to aggregate even after reaching their solubility limit in water (Figure S3). The highly constrained geometrical molecular arrangement of the new glycosylated BODIPYs entailed an enhanced water solubility while hindering any intermolecular exciton coupling of these inherently hydrophobic chromophores. Thus, it appears that the conformational rigidity asserted by the direct linkage of the bulky saccharides at positions C2 and C6 and the orthogonal disposition of the 8-aryl moiety with respect to the main plane of the chromophoric framework hampered the stacking of the boradiazaindacene units in concentrated water solutions. This phenomenon was even reinforced when a third hydrophilic, bulky, sugar unit was incorporated at one of the apical positions of the BODIPY chromophore, as in 14, thus shielding one of the faces perpendicular to the BODIPY core.9b Therefore, C-glycosylation of the BODIPY skeleton might then be visualized as a concise and suitable strategy for fine-tuning its water solubility while keeping a notable fluorescence response even in high-optical density media.

Understanding laser-induced photophysical behavior is key in the engineering of photonic materials for advanced applications such as high-resolution microscopy techniques involving laser radiation as an excitation source. Therefore, the lasing properties of the new glycosylated derivatives were studied, according to their absorption properties, under pumping radiation at both 355 and 532 nm. Laser emission, centered in the 556–568 nm spectral region, was recorded from the new dyes with efficiencies of ≤22% (see Table S2). A further important parameter is the dye photostability over long operation times. Long-lasting efficient emitters under lasing irradiation are sought to reach the nominal resolution of the most advanced optical microscopy. The photostability of the new dyes was analyzed by the decay of its laser-induced fluorescence (LIF) intensity in an ethyl acetate solution upon severe laser pumping (see the Supporting Information for experimental details). All of the glyco-BODIPYs studied (acylated and saponified derivatives) displayed a high photostability because their LIF emission decreased by merely 10% of its initial value after 70000 pump pulses at a repetition rate of 10 Hz.

The spectral bands of the urea-bridged bis-BODIPYs featuring C2,C6 carbohydrate units (15 and 16) showed profiles similar to those described above for the small-molecule saccharidic BODIPYs, but with higher molar absorption coefficients, owing to the additive contribution of both chromophoric subunits in the dimer (Figure S4). Unprotected bis-BODIPY 16 showed a limited water solubility, being fully dissolved just in the micromolar range. The appended carbohydrates were likely not able to efficiently decrease the hydrophobic nature of the dimeric urea. The fluorescence response of 16 is lower than that of its corresponding monomeric precursor, especially in polar media (Figure 5 and Table S3). Similar results were previously reported for nonglycosylated urea-bridged bis-BODIPYs.22,24 As mentioned above, each chromophoric fragment retains its molecular identity after covalent assembly, thus showing isoenergetic excited states and electronic transitions that enable energy and electron transfer processes. The migration of energy between bridged BODIPY units could quench the fluorescence through the dissipation of excitation energy as heat, but it solely cannot explain the marked solvent-sensitive fluorescence response of 16. Such polarity-triggered fluorescence quenching was ascribed to an additional nonradiative pathway such as photoinduced electron transfer (PET) between the pair of identical BODIPYs electronically decoupled in the ground state.2225 This electron transfer mechanism with no electrostatic driving force is enhanced by the solvent polarity, thus decreasing the fluorescence efficiency in polar media (Figure 5 and Table S3).

Even though this PET process was detrimental to the fluorescence response, it paved the way to new photoinduced pathways. In fact, the ability of electron transfer to mediate in the triplet state population is actively applied to develop heavy atom-free singlet oxygen photosensitizers for photodynamic therapy (PDT).26 Against this background, and bearing in mind the aforementioned ongoing PET in the glycosylated bis-BODIPY,22 we analyzed its suitability to generate singlet oxygen in chloroform. Bis-BODIPY 16 yielded a singlet oxygen generation efficiency of 12%, while retaining a fluorescence response of 58% in this solvent (Table S3). Therefore, this bis-glyco-BODIPY could be envisaged as an effective theranostic agent allowing simultaneously imaging (fluorescence) and phototreatment (singlet oxygen generation). Note that the rest of the herein reported monomeric glycoprobes (13 and 14) did not display such emission, supporting the key role on the PET in mediating the population of the triplet manifold and overall in the fluorescence signatures of bis-BODIPYs.

In summary, we have reported a concise method for the incorporation of at least two sugar units at C2 and C6 into the BODIPY core in 8-aryl 1,3,5,7-tetramethyl BODIPYs by direct Ferrier-type C-glycosylation of the boradiaza-s-indacene core. The presence of an aryl group at C8 appeared to be necessary for the reaction to succeed, probably by stabilizing positively charged reactive species because a related meso-methyl BODIPY underwent extensive decomposition. The constrained geometry of these C-glycosyl BODIPYs avoids aggregation in highly concentrated aqueous media, thus showing improved water solubility while retaining a bright and stable emission. In addition, the ongoing PET in water-soluble glycosylated bis-BODIPYs enables singlet oxygen generation while retaining a fluorescence response being suited for theranostic purposes.

Experimental Section

General Information

All solvents and reagents were obtained commercially and used as received unless stated otherwise. Residual water was removed from starting compounds by repeated co-evaporation with toluene. All moisture-sensitive reactions were performed in dry flasks fitted with glass stoppers or rubber septa under a positive pressure of argon. Anhydrous MgSO4 or Na2SO4 was used to dry organic solutions during workup. Evaporation of the solvents was performed under reduced pressure using a rotary evaporator. Flash column chromatography was performed using 230–400 mesh silica gel. Thin-layer chromatography was conducted on Kieselgel 60 F254. Spots were observed first under UV irradiation (254 nm) and then by charring with a solution of 20% aqueous H2SO4 (200 mL) in AcOH (800 mL). All melting points were determined with a Stuart SMP-20 apparatus. Optical rotations were measured on a Jasco P2000 polarimeter with [α]D25 values reported in degrees with concentrations expressed in grams per 100 mL. 1H and 13C NMR spectra were recorded in CDCl3 or CD3OD at 300, 400, or 500 MHz and 75, 101, or 126 MHz, respectively. Chemical shifts are expressed in parts per million (δ) downfield from tetramethylsilane and are referenced to residual protium in the NMR solvent (CHCl3, δ 7.25; CH3OH, δ 4.87). Coupling constants (J) are given in hertz. All presented 13C NMR spectra are proton-decoupled. Mass spectra were recorded by direct injection with an Accurate Mass Q-TOF LC/MS spectrometer equipped with an electrospray ion source in positive mode.

General Method for the BF3·OEt2-Catalyzed Ferrier Reaction of BODIPYs with Acetylated Glucal 8

To a stirred solution of tri-O-acetyl-d-glucal 8 (3–5 equiv) and the appropriate BODIPY (1 equiv) in anhydrous CH2Cl2 (20 mL/mmol) was added 4 Å molecular sieves. The mixture was stirred at room temperature (rt) for ∼15 min under an Ar atmosphere and then cooled to −20 °C. BF3·OEt2 (0.15 equiv) was then added. The mixture was stirred under these conditions for 45–90 min, poured into 5 mL of a saturated aqueous NaHCO3 solution, and partitioned twice with 10 mL of CH2Cl2. The combined organic layers were washed once with brine, dried over MgSO4, and filtered, and the solvent was removed in vacuo. The crude material was purified through silica gel column chromatography.

2,6-Bis(4,6-di-O-acetyl-2,3-dideoxy-β-d-erythro-hex-2-enopyranosyl)-8-phenyl-1,3,5,7-tetramethyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (9)

BODIPY 6a (80 mg, 0.25 mmol) was reacted with tri-O-acetyl-d-glucal 8 (204 mg, 0.75 mmol) and BF3·OEt2 (4.6 μL, 0.04 mmol) following the general procedure (−20 °C, 45 min). The residue was purified by flash silica gel chromatography (9:1 hexane/ethyl acetate) to give derivative 9 (127 mg, 68%): red solid; mp 82–83 °C; [α]D21 = +98.1 (c 0.025, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.49–7.46 (m, 3H), 7.23–7.20 (m, 2H), 5.83–5.73 (m, 4H), 5.36–5.32 (m, 2H), 5.20–5.18 (m, 2H), 4.22 (dd, J = 12.1, 2.5 Hz, 2H), 4.13 (dd, J = 12.1, 5.3 Hz, 2H), 3.85 (ddd, J = 9.1, 5.3, 2.5 Hz, 2H), 2.57 (s, 6H), 2.08 (s, 6H), 2.04 (s, 6H), 1.34 (s, 6H); 13C{1H} NMR (75 MHz, CDCl3) δ 171.0, 170.4, 155.3, 142.6, 141.3, 135.1, 133.8, 131.6, 131.0, 129.4, 129.3, 129.0, 128.6, 128.0, 127.8, 125.2, 75.0, 69.9, 65.1, 63.5, 21.1, 20.8, 13. 4, 12.2; HRMS (ESI) m/z calcd for [M + H]+ C39H44BF2N2O10 749.3058, found 749.3051; HRMS (ESI) m/z calcd for [M + NH4]+ C39H47BF2N3O10 766.3313, found 766.3324.

2,6-Bis(4,6-di-O-acetyl-2,3-dideoxy-β-d-erythro-hex-2-enopyranosyl)-8-(2-azidomethyl)-phenyl-1,3,5,7-tetramethyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (11)

BODIPY 6b (130 mg, 0.34 mmol) was reacted with tri-O-acetyl-d-glucal 8 (280 mg, 1.03 mmol) and BF3·OEt2 (6 μL, 0.05 mmol) following the general procedure (−20 °C, 45 min). The residue was purified by flash silica gel chromatography (9:1 toluene/ethyl acetate) to give derivative 11 (191 mg, 70%): red solid; mp 68–69 °C; [α]D21 = −60.5 (c 0.025, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.58–7.53 (m, 2H), 7.45 (td, J = 7.5, 1.7 Hz, 1H), 7.19 (d, J = 7.5 Hz, 1H), 5.83–5.75 (m, 4H), 5.36–5.34 (m, 2H), 5.20–5.19 (m, 2H), 4.32 (bs, 2H), 4.24 (dd, J = 12.2, 2.3 Hz, 2H), 4.16–4.11 (m, 2H), 3.87–3.84 (m, 2H), 2.58 (s, 6H), 2.09 (s, 6H), 2.06 (s, 6H), 1.323 (s, 3H), 1.317 (s, 3H); 13C{1H} (126 MHz, CDCl3) δ 171.1, 170.4, 156.3, 156.1, 140.9, 140.7, 139.8, 134.0, 133.7, 131.50, 131.48, 130.2, 129.2, 129.0, 128.7, 125.42, 125.37, 75.12, 75.07, 69.98, 69.88, 65.11, 65.08, 63.5, 52.1, 21.2, 21.0, 13.6, 13.5, 11.78, 11.75; HRMS (ESI) m/z calcd for [M + H]+ C40H45BF2N5O10 804.3229, found 804.3249.

2,6-Bis(4,6-di-O-acetyl-2,3-dideoxy-β-d-erythro-hex-2-enopyranosyl)-8-[(4,6-di-O-acetyl-2,3-dideoxy-α-d-erythro-hex-2-enopyranosyl)-2-methylphenyl]-1,3,5,7-tetramethyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (12)

BODIPY 6c (50 mg, 0.14 mmol) was reacted with tri-O-acetyl-d-glucal 8 (193 mg, 0.71 mmol) and BF3·OEt2 (3 μL, 0.02 mmol) following the general procedure (−20 °C, 90 min). The residue was purified by flash silica gel chromatography (7:3 toluene/ethyl acetate) to give derivative 12 (101 mg, 72%): red solid; mp 88–89 °C; [α]D21 = +96.8 (c 0.02, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.56 (dd, J = 7.2, 1.5 Hz, 1H), 7.50 (dt, J = 7.5, 1.0 Hz, 1H), 7.44 (dt, J = 7.5, 1.0 Hz, 1H), 7.17 (dd, J = 7.2, 1.0 Hz, 1H), 5.83–5.59 (m, 5H), 5.34–4.97 (m, 7H), 4.69 (d, J = 11.6 Hz, 1H), 4.36 (d, J = 11.6 Hz, 1H), 4.25–3.83 (m, 9H), 2.58 (s, 6H), 2.09 (s, 3H), 2.085 (s, 3H), 2.078 (s, 3H), 2.054 (s, 3H), 2.050 (s, 3H), 2.01 (s, 3H), 1.33 (s, 3H), 1.32 (s, 3H); 13C{1H} (101 MHz, CDCl3) δ 171.1, 170.8, 170.5, 170.3, 156.0, 155.5, 141.2, 140.6, 135.3, 134.3, 131.6, 130.7, 130.5, 129.9, 129.8, 129.7, 129.2, 128.7, 128.5, 128.4, 128.0, 127.9, 127.3, 125.4, 125.3, 94.7, 75.0, 70.0, 69.8, 68.5, 67.2, 65.1, 63.5, 62.6, 21.2, 21.14, 21.10, 20.95, 20.89, 20.85, 13.7, 13.4, 11.9, 11.7; HRMS (ESI) m/z calcd for [M + NH4]+ C50H61BF2N3O16 1008.4116, found 1008.4130.

Hydrogenation Reaction of 9

2,6-Bis(4,6-di-O-acetyl-2,3-dideoxy-β-d-erythro-hex-2-pyranosyl)-8-phenyl-1,3,5,7-tetramethyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (10). A solution of compound 9 (40 mg, 0.05 mmol) in a MeOH/CH2Cl2 mixture [3 mL, 1:1 (v/v)] was hydrogenated in a Parr hydrogenator with 10% Pd:C [10% (w/w)] at 25 psi. After reaction for 16 h, the catalyst was filtered off, the filtrate evaporated under reduced pressure, and the residue purified by flash chromatography (9:1 hexane/ethyl acetate) to give 10 (31 mg, 80%): red oil; [α]D21 = +212.3 (c 0.13, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.49–7.47 (m, 2H), 7.26–7.23 (m, 3H), 4.75 (dt, J = 10.0, 4.7 Hz, 2H), 4.39 (dd, J1,2 = 11.6, 2.5 Hz, 2H), 4.18–4.16 (m, 4H), 3.59 (dt, J = 10.0, 3.4 Hz, 2H), 2.63 (s, 6H), 2.31–2.24 (m, 2H), 2.05 (s, 6H), 2.04 (s, 6H), 2.00–1.82 (m, 2H), 1.74–1.49 (m, 4H) 1.35 (s, 6H); 13C NMR (101 MHz, CDCl3) δ 171.4, 170.6, 154.6, 142.4, 139.9, 135.6, 131.4, 130.2, 129.7, 129.5, 128.5, 78.2, 73.8, 68.1, 63.6, 30.9, 30.0, 21.6, 21.3, 14.0, 12.6; HRMS (ESI) m/z calcd for [M + H]+ C39H48BF2N2O10 753.3371, found 753.3365.

General Method for the Methanolysis of Acetate Esters

A solution of the corresponding acetate (0.1 mmol) in MeOH (2 mL) was treated with Et3N (0.5 mL). The mixture was warmed at 60 °C (heat-on blocks) and stirred at that temperature overnight. The solution was concentrated in vacuo, and the residue was then purified by flash column chromatography (eluent, dichloromethane/methanol mixtures).

2,6-Bis(2,3-dideoxy-β-d-erythro-hex-2-enopyranosyl)-8-phenyl-1,3,5,7-tetramethyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (13a)

BODIPY 9 (45 mg, 0.06 mmol) was deacylated according to the general procedure (60 °C, heat-on block, overnight). The residue was purified by flash silica gel chromatography (95:5 dichloromethane/methanol) to give derivative 13a (31 mg, 90%): red solid; mp 160–161 °C; [α]D21 = +473.1 (c 0.03, CH3OH); 1H NMR (500 MHz, CD3OD) δ 7.58–7.55 (m, 3H), 7.33–7.30 (m, 2H), 5.85 (dt, J = 10.5, 2.0 Hz, 2H), 5.68 (dt, J = 10.5, 2 Hz, 2H), 5.21–5.20 (m, 2H), 4.09–4.06 (m, 2H), 3.87 (dd, J = 12.0, 2.0 Hz, 2H), 3.65 (dd, J = 12.0, 6.5 Hz, 2H), 3.46 (ddd, J = 12.0, 6.5, 2.5 Hz, 2H), 2.53 (s, 6H), 1.39 (s, 6H); 13C{1H} (126 MHz, CD3OD) δ 155.2, 142.5, 140.7, 135.0, 130.5, 129.40, 129.37, 129.1, 128.98, 128.96, 127.95, 80.8, 69.3, 62.7, 61.9, 12.2, 10.9; HRMS (ESI) m/z calcd for [M + H]+ C31H36BF2N2O6 581.2634, found 581.2621.

2,6-Bis(2,3-dideoxy-β-d-erythro-hex-2-enopyranosyl)-8-(2-azidomethyl)-phenyl-1,3,5,7-tetramethyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (13b)

BODIPY 11 (59 mg, 0.07 mmol) was deacylated according to the general procedure (60 °C, heat-on block, overnight). The residue was purified by flash silica gel chromatography (95:5 dichloromethane/methanol) to give derivative 13b (31 mg, 67%): mp 135–136 °C; [α]D21 = +1090.2 (c 0.025, CH3OH); 1H NMR (400 MHz, CD3OD) δ 7.60–7.50 (m, 3H), 7.24–7.27 (m, 1H), 5.82 (d, J = 10.2 Hz, 2H), 5.66 (dt, J = 10.2, 2.0 Hz, 2H), 5.17 (bs, 2H), 4.28–4.30 (m, 2H), 4.06–4.02 (m, 2H), 3.86–3.82 (m, 2H), 3.65–3.60 (m, 2H), 3.45–3.42 (m, 2H), 2.53 (s, 6H), 1.36 (s, 6H); 13C{1H} (101 MHz, CD3OD) δ 155.9, 155.8, 140.64, 140.59, 139.8, 134.2, 134.1, 130.2, 129.8, 129.60, 129.56, 129.37, 129.33, 129.28, 129.2, 128.8, 80.93, 80.90, 69.35, 69.33, 62.81, 62.78, 61.9, 51.8, 12.4, 10.7, 10.6; HRMS (ESI) m/z calcd for [M + H]+ C32H37BF2N5O6 636.2805, found 636.2776; HRMS (ESI) m/z calcd for [M + NH4]+ C32H40BF2N6O6 653.3070, found 653.3042.

2,6-Bis(2,3-dideoxy-β-d-erythro-hex-2-enopyranosyl)-8-[(2,3-dideoxy-α-d-erythro-hex-2-enopyranosyl)-2-methyl-phenyl]-1,3,5,7-tetramethyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (14)

BODIPY 12 (42 mg, 0.04 mmol) was deacylated according to the general procedure (60 °C, heat-on block, overnight). The residue was purified by flash silica gel chromatography (9:1 dichloromethane/methanol) to give derivative 14 (18 mg, 62%): red solid; mp 148–150 °C; [α]D21 = +354.6 (c 0.04, CH3OH); 1H NMR (400 MHz, CD3OD) δ 7.63 (d, J = 7.5 Hz, 1H), 7.55–7.46 (m, 2H), 7.20 (d, J = 7.5 Hz, 1H), 5.92–5.62 (m, 4H), 5.53 (d, J = 10.3 Hz, 1H), 5.17 (s, 2H), 4.72–4.60 (m, 4H), 4.29 (d, J = 11.2 Hz, 1H), 4.06–4.01 (m, 3H), 3.84 (d, J = 11.5 Hz, 2H), 3.66–3.56 (m, 6H), 2.52 (s, 6H), 1.35 (s, 3H), 1.33 (s, 3H); 13C{1H} (101 MHz, CD3OD) δ 156.7, 156.6, 142.7, 142.2, 137.0, 135.7, 134.9, 131.6, 131.0, 130.9, 130.8, 130.6, 130.3, 130.2, 129.4, 126.8, 95.6, 82.3, 82.2, 73.5, 70.70, 70.67, 68.8, 64.1, 63.7, 63.3, 63.2, 62.2, 13.6, 12.03, 11.99; HRMS (ESI) m/z calcd for [M + NH4]+ C38H49BF2N3O10 756.3480, found 756.3479.

General Method for the Ureation Reaction

The appropriate azidomethyl-BODIPY (1 mmol) was added to a mixture of 1 M triethylammonium hydrogen carbonate buffer (TEAB) (2.6 mL) and 1,4-dioxane (6 mL) at room temperature. Triphenylphosphine (1.3 equiv) was added, and the reaction was monitored by TLC. After disappearance of the starting material, the solvent was evaporated in vacuo to dryness. The obtained BODIPY dimers were purified by flash chromatography on silica gel.

Compound 15

Azidomethyl-BODIPY 11 (40 mg, 0.05 mmol) was reacted with PPh3 (20 mg, 0.075 mmol) and TEAB (200 μL, 1 M solution, 0.2 mmol) following the general procedure (rt, overnight). The residue was purified by flash silica gel chromatography (7:3 hexane/ethyl acetate) to give derivative 15 (31 mg, 80%): red solid; mp 91–92 °C; [α]D21 = +563.0 (c 0.02, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.47 (d, J = 8.0 Hz, 2H), 7.43 (t, J = 7.5 Hz, 2H), 7.33 (t, J = 7.5 Hz, 2H), 7.08 (d, J = 7.8 Hz, 2H), 5.79–5.68 (m, 8H), 5.33–5.16 (m, 10H), 4.28–3.80 (m, 16H),, 2.52 (s, 6H), 2.50 (s, 6H), 2.07 (s, 12H), 2.02 (s, 6H), 2.00 (s, 6H), 1.31 (s, 6H), 1.26 (s, 3H); 13C{1H} NMR (126 MHz, CDCl3) δ 171.2, 171.0, 170.4, 158.0, 155.5, 155.4, 141.3, 141.15, 141.11, 137.5, 137.4, 132.9, 132.9, 132.1, 132.0, 131.55, 131.50, 130.48, 130.42, 129.9, 128.7, 128.6, 128.5, 128.15, 128.10, 128.08, 128.0, 125.12, 125.08, 75.03, 74.97, 69.9, 69.8, 65.1, 65.0, 63.4, 63.3, 41.7, 21.1, 20.94, 20.89, 20.76, 13.3, 13.2, 11.71, 11.69; HRMS (ESI) m/z calcd for [M + H]+ C81H91B2F4N6O21 1581.6378, found 1581.6376; HRMS (ESI) m/z calcd for [M + NH4]+ C81H94B2F4N7O21 1598.6643, found 1598.6628.

Compound 16

Azidomethyl-BODIPY 14 (26 mg, 0.04 mmol) was reacted with PPh3 (16 mg, 0.06 mmol) and TEAB (170 μL, 0.16 mmol) following the general procedure (rt, overnight). The residue was purified by flash silica gel chromatography (9:1 dichloromethane/methanol) to give derivative 16 (19 mg, 78%): red solid; mp >300 °C; [α]D21 +664.2 (c 0.03, CH3OH); 1H NMR (400 MHz, CD3OD) δ 7.52–7.41 (m, 6H), 7.17 (dd, J = 7.5, 1.4 Hz, 2H), 5.85–5.79 (m, 6H), 5.70 (dt, J = 10.2, 1.8 Hz, 2H), 5.21–5.18 (m, 4H), 4.25 (d, J = 16.2 Hz, 2H), 4.11–4.03 (m, 6H), 3.87–3.70 (m, 4H), 3.68–3.60 (m, 4H), 3.49–3.41 (m, 4H), 2.51 (s, 6H), 2.46 (s, 6H), 1.39 (s, 6H), 1.36 (s, 6H); 13C{1H} NMR (101 MHz, CD3OD) δ 159.8, 156.9, 156.4, 142.24, 142.16, 141.6, 139.3, 134.7, 131.6, 131.3, 130.8, 130.74, 130.70, 130.64, 130.60, 130.5, 130.2, 129.5, 129.4, 129.1, 82.2, 82.1, 70.8, 70.7, 64.1, 64.0, 63.3, 42.4, 13.7, 11.98, 11.92, 11.89; HRMS (ESI) m/z calcd for [M + H]+ C65H75B2F4N6O13 1245.5529, found 1245.5552; HRMS (ESI) m/z calcd for [M + Na]+ C65H74B2F4N6NaO13 1267.5348, found 1267.5388.

Photophysical Properties

The photophysical properties were registered in diluted solutions (∼2 × 10–6 M) and prepared by adding the corresponding solvent (spectroscopic grade, used without furher purification or drying) to the residue from the adequate amount of a concentrated stock solution in acetone, after vacuum evaporation of this solvent. UV–vis absorption and fluorescence (after excitation at 480 nm) spectra were recorded on a Varian model CARY 4E spectrophotometer and an Edinburgh Instruments spectrofluorimeter (model FLSP 920), respectively, using quartz cuvettes with an optical path length of 1 cm. Fluorescence quantum yields (ϕ) were obtained using PM567 (laser grade from Exciton, ϕ = 0.84 in ethanol) as a reference, from corrected spectra (detector sensibility to the wavelength). The values were corrected by the refractive index of the solvent. Radiative decay curves were registered with the time-correlated single-photon counting technique as implemented in the aforementioned spectrofluorimeter. Fluorescence emission was monitored at the maximum emission wavelength (520–525 nm) after excitation (at 500 nm) by means of a Fianium pulsed laser (time resolution of picoseconds) with a tunable wavelength. The fluorescence lifetime (t) was obtained after the deconvolution of the instrumental response signal from the recorded decay curves by means of an iterative method. The goodness of the exponential fit was controlled by statistical parameters (χ2 and the analysis of the residuals). The radiative (kfl) and nonradiative (knr) rate constants were calculated from the fluorescence quantum yield and average lifetime; kfl = ϕ/τ, and knr = (1 – ϕ)/τ.

The photophysical properties at high concentrations in aqueous solutions (Milli-Q water) were recorded using cuvettes with the required optical path length (l) to minimize the re-absorption/re-emission phenomena at each concentration (10–4 M – l = 0.01 cm, and 2 × 10–5 M – l = 0.1 cm). The fluorescence spectra were recorded in the front-face configuration.

The photoinduced production of singlet oxygen (1O2) was determined by direct measurement of the luminescence at 1276 nm with a NIR detector integrated in the aforementioned spectrofluorometer (InGaAs detector, Hamamatsu G8605-23). The 1O2 signal was registered in the front configuration (front face), 40° and 50° to the excitation and emission beams, respectively, and leaned 30° to the plane formed by the direction of incidence and registration in cells of 1 cm. The signal was filtered by a low cutoff of 850 nm. The 1O2 generation quantum yield (ϕΔ) was determined using the equation

graphic file with name jo1c00413_m001.jpg

where ϕΔ,r is the quantum yield of 1O2 generation for the used reference (in our case, phenalenone). Factor α = 1 – 10–Abs corrects the different amount of photons absorbed by the sample (αPs) and reference (αR). Factor Se is the intensity of the 1O2 phosphorescence signal of the sample (SePs) and the reference (Ser) at 1276 nm. Phenalenone in chloroform was used as a reference for visible irradiation (420 nm), its singlet oxygen quantum yield being ϕΔ = 0.98. 1O2 quantum yields were averaged from five concentrations between 10–6 and 10–5 M in chloroform (spectroscopic grade).

Quantum Mechanic Calculations

Ground state geometries were optimized with the b3lyp hybrid functional, within density functional theory, using the triple valence basis set with one polarization function (6-311g*). The geometries were considered as energy minima when the corresponding frequency analysis did not give any negative value. All of the calculations were conducted with Gaussian 16.

Lasing Properties

The laser efficiency was evaluated from concentrated solutions (millimolar) of dyes in ethyl acetate contained in 1 cm optical path length rectangular quartz cells carefully sealed to avoid solvent evaporation during experiments. The liquid solutions were transversely pumped with 5 mJ, 8 ns fwhm pulses from the second (532 nm) and third (355 nm) harmonics of a Q-switched Nd:YAG laser (Lotis TII 2134) at a repetition rate of 1 Hz. The exciting pulses were line-focused onto the cell using a combination of positive and negative cylindrical lenses (f = 15 and −15 cm, respectively) perpendicularly arranged. The plane parallel oscillation cavity (2 cm length) consisted of a 90% reflectivity aluminum mirror acting as the back reflector, and the lateral face of the cell acting as the output coupler (4% reflectivity). The pump and output energies were detected by a GenTec power meter. The photostability of the dyes in an ethyl acetate solution was evaluated by using a pumping energy and geometry exactly equal to those of the laser experiments. We used spectroscopic quartz cuvettes with a 0.1 cm optical length to allow the minimum solution volume (40 μL) to be excited. The lateral faces were grounded, whereupon no laser oscillation was obtained. Information about photostabilitiy was obtained by monitoring the decrease in the laser-induced fluorescence (LIF) intensity after 70000 pump pulses and a repetition rate of 10 Hz to accelerate the experimental running. The fluorescence emission and laser spectra were monitored perpendicular to the exciting beam, collected by an optical fiber, imaged with a spectrometer (Acton Research Corp.), and detected with a charge-coupled device (SpectruMM:GS128B). The fluorescence emission was recorded by feeding the signal into the boxcar (Stanford Research, model 250) to be integrated before being digitized and processed by a computer. The estimated error in the energy and photostability measurements was 10%.

Acknowledgments

The authors gratefully acknowledge the Spanish Ministerio de Ciencia e Innovación for financial support (Projects RTI2018-094862-B-100, MAT2017-83856-C3-1-P and -3-P, and PiD2020-114755GB-C31 and -C33) and the Gobierno Vasco (Project IT912-16) for financial support. The authors are indebted to Mr. Diego Pozas and Ms. Marina Rodríguez (IQOG-CSIC) for skillful technical support. A.O.-S. thanks UPV/EHU for her predoctoral fellowship.

Supporting Information Available

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.joc.1c00413.

  • Copies of 1H and 13C NMR spectra, photophysical studies for some of the derivatives, and atom coordinates and total energies (in hartrees) in the ground state (b3lyp/6-311G*) for glyco-BODIPYs (13a, 13b, 14, and 16) (PDF)

The authors declare no competing financial interest.

Dedication

This article is dedicated to the memory of our mentor (A.M.G., J.C.L.) Prof. Bert Fraser-Reid (1934−2020).

Supplementary Material

jo1c00413_si_001.pdf (3.1MB, pdf)

References

  1. a Stephens D. J.; Allan V. J. Light microscopy techniques for live cell imaging. Science 2003, 300, 82–86. 10.1126/science.1082160. [DOI] [PubMed] [Google Scholar]; b Yuan L.; Lin W.; Zheng K.; He L.; Huang W. Far-red to near infrared analyte-responsive fluorescent probes based on organic fluorophore platforms for fluorescence imaging. Chem. Soc. Rev. 2013, 42, 622–661. 10.1039/C2CS35313J. [DOI] [PubMed] [Google Scholar]
  2. a Lu H.; Mack J.; Yang Y.; Shen Z. Structural modification strategies for the rational design of red/NIR region BODIPYs. Chem. Soc. Rev. 2014, 43, 4778–4823. 10.1039/C4CS00030G. [DOI] [PubMed] [Google Scholar]; b Kowada T.; Maeda H.; Kikuchi K. BODIPY-based probes for the fluorescence imaging of biomolecules in living cells. Chem. Soc. Rev. 2015, 44, 4953–4972. 10.1039/C5CS00030K. [DOI] [PubMed] [Google Scholar]
  3. a Loudet A.; Burgess K. BODIPY dyes and their derivatives: syntheses and spectroscopic properties. Chem. Rev. 2007, 107, 4891–4932. 10.1021/cr078381n. [DOI] [PubMed] [Google Scholar]; b Bañuelos J. BODIPY Dye, the most versatile fluorophore ever?. Chem. Rec 2016, 16, 335–348. 10.1002/tcr.201500238. [DOI] [PubMed] [Google Scholar]; c Kolemen S.; Akkaya E. U. Reaction-based BODIPY probes for selective bio-imaging. Coord. Chem. Rev. 2018, 354, 121–134. 10.1016/j.ccr.2017.06.021. [DOI] [Google Scholar]
  4. a Boens N.; Verbelen B.; Dehaen W. Postfunctionalization of the BODIPY core: synthesis and spectroscopy. Eur. J. Org. Chem. 2015, 2015, 6577–6595. 10.1002/ejoc.201500682. [DOI] [Google Scholar]; b Boens N.; Verbelen B.; Ortiz M. J.; Jiao L.; Dehaen W. Synthesis of BODIPY dyes through postfunctionalization of the boron dipyrromethene core. Coord. Chem. Rev. 2019, 399, 213024. 10.1016/j.ccr.2019.213024. [DOI] [Google Scholar]
  5. a Romieu A.; Massif C.; Rihn S.; Ulrich G.; Ziessel R.; Renard P.-Y. The first comparative study of the ability of different hydrophilic groups to water-solubilise fluorescent BODIPY dyes. New J. Chem. 2013, 37, 1016–1027. 10.1039/c3nj41093e. [DOI] [Google Scholar]; b Kolemen S.; Akkaya E. U. Reaction-based BODIPY probes for selective bio-imaging. Coord. Chem. Rev. 2018, 354, 121–134. 10.1016/j.ccr.2017.06.021. [DOI] [Google Scholar]; c Agazzi M. L.; Ballatore M. B.; Durantini A. M.; Durantini E. N.; Tomé A. C. BODIPYs in antitumoral and antimicrobial photodynamic therapy: an integrating review. J. Photochem. Photobiol., C 2019, 40, 21–48. 10.1016/j.jphotochemrev.2019.04.001. [DOI] [Google Scholar]
  6. Selected references:; a Franke J. M.; Raliski B. K.; Boggess S. C.; Natesan D. V.; Koretsky E. T.; Zhang P.; Kulkarni R. U.; Deal P. E.; Miller E. W. BODIPY fluorophores for membrane potential imaging. J. Am. Chem. Soc. 2019, 141, 12824–12831. 10.1021/jacs.9b05912. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Wang M.; Zhang G.; Bobadova-Parvanova P.; Merriweather A. N.; Odom L.; Barbosa D.; Fronczek F. R.; Smith K. M.; Vicente M. G. H. Synthesis and investigation of linker-free BODIPY-Gly conjugates substituted at boron. Inorg. Chem. 2019, 58, 11614–11621. 10.1021/acs.inorgchem.9b01474. [DOI] [PubMed] [Google Scholar]; c Kand D.; Liu P.; Navarro M. X.; Fischer L. J.; Rousso-Noori L.; Friedmann-Morvinski D.; Winter A. H.; Miller E. W.; Weinstain R. Water-soluble BODIPY photocages with tunable cellular localization. J. Am. Chem. Soc. 2020, 142, 4970–4974. 10.1021/jacs.9b13219. [DOI] [PMC free article] [PubMed] [Google Scholar]; d Yanai H.; Hoshikawa S.; Moriiwa Y.; Shoji A.; Yanagida A.; Matsumoto T.. A fluorinated carbanionic substituent for improving water solubility and lipophilicity of fluorescent dyes Angew. Chem., Int. Ed.. 2021, 60, 5168. 10.1002/anie.202012764. [DOI] [PubMed] [Google Scholar]
  7. See also:Blázquez-Moraleja A.; Álvarez-Fernández D.; Prieto-Montero R.; García-Moreno I.; Martínez-Martínez V.; Bañuelos J.; Sáenz-de-Santa-María I.; Chiara M. D.; Chiara J. L. A general modular approach for the solubility tagging of BODIPY dyes. Dyes Pigm. 2019, 170, 107545. 10.1016/j.dyepig.2019.107545. [DOI] [Google Scholar]; and references on water-solubilizing approaches cited therein
  8. In a conceptually different approach, BODIPYs have also been used to tag water-soluble compounds. See, for instance:; a Subiros-Funosas R.; Mendive-Tapia L.; Sot J.; Pound J. D.; Barth N.; Varela Y.; Goñi F. M.; Paterson M.; Gregory C. D.; Albericio F.; Dransfield I.; Lavilla R.; Vendrell M. A Trp-BODIPY cyclic peptide for fluorescence labelling of apoptotic bodies. Chem. Commun. 2017, 53, 945–948. 10.1039/C6CC07879F. [DOI] [PubMed] [Google Scholar]; b Anai Y.; Shichijo K.; Fujitsuka M.; Hisaeda Y.; Shimakoshi H. Synthesis of a B12-BODIPY dyad for B12-inspired photochemical transformations of a trichloromethylated organic compound. Chem. Commun. 2020, 56, 11945–11948. 10.1039/D0CC04274A. [DOI] [PubMed] [Google Scholar]
  9. a Vu T. T.; Dvorko M.; Schmidt E. Y.; Audibert J.-F.; Retailleau P.; Trofimov B. A.; Pansu R. B.; Clavier G.; Méallet-Renault R. Understanding the spectroscopic properties and aggregation process of a new emitting boron dipyrromethene (BODIPY). J. Phys. Chem. C 2013, 117, 5373–5385. 10.1021/jp3097555. [DOI] [Google Scholar]; b Doulain P.-E.; Goze C.; Bodio E.; Richard P.; Decréau R. A. BODIPY atropisomer interconversion, face discrimination, and superstructure appending. Chem. Commun. 2016, 52, 4474–4477. 10.1039/C5CC10526A. [DOI] [PubMed] [Google Scholar]; c Descalzo A. B.; Ashokkumar P.; Shen Z.; Rurack K. On the aggregation behavior and spectroscopic properties of alkylated and annelated boron-dipyrromethene (BODIPY) dyes in aqueous solution. ChemPhotoChem. 2020, 4, 120–131. 10.1002/cptc.201900235. [DOI] [Google Scholar]
  10. a He X.-P.; Zang Y.; James T. D.; Li J.; Chen G.-R.; Xie J. Fluorescent glycoprobes: a sweet addition for improved sensing. Chem. Commun. 2017, 53, 82–90. 10.1039/C6CC06875H. [DOI] [PubMed] [Google Scholar]; b Thomas B.; Yan K.-C.; Hu X.-L.; Donnier-Maréchal M.; Chen G.-R.; He X.-P.; Vidal S. Fluorescent glycoconjugates and their applications. Chem. Soc. Rev. 2020, 49, 593–641. 10.1039/C8CS00118A. [DOI] [PubMed] [Google Scholar]
  11. a Papalia T.; Siracusano G.; Colao I.; Barattucci A.; Aversa M. C.; Serroni S.; Zappala G.; Campagna S.; Sciortino M. T.; Puntoriero F.; Bonaccorsi P. Cell internalization of BODIPY-based fluorescent dyes bearing carbohydrate residues. Dyes Pigm. 2014, 110, 67–71. 10.1016/j.dyepig.2014.05.022. [DOI] [Google Scholar]; b Martinez-Gonzalez M. R.; Urías-Benavides A.; Alvarado-Martínez E.; Lopez J. C.; Gomez A. M.; del Rio M.; Garcia I.; Costela A.; Bañuelos J.; Arbeloa T.; Lopez Arbeloa I.; Peña-Cabrera E. Convenient access to carbohydrate-BODIPY hybrids by two complementary methods involving one-pot assembly of “clickable” BODIPY dyes. Eur. J. Org. Chem. 2014, 2014, 5659–5663. 10.1002/ejoc.201402767. [DOI] [Google Scholar]; c Zhang Q.; Cai Y.; Li Q.-Y.; Hao L.-N.; Ma Z.; Wang X.-J.; Yin J. Targeted delivery of a mannose-conjugated BODIPY photosensitizer by nanomicelles for photodynamic breast cancer therapy. Chem. - Eur. J. 2017, 23, 14307–14315. 10.1002/chem.201702935. [DOI] [PubMed] [Google Scholar]; d Baratucci A.; Campagna S.; Papalia T.; Galleta M.; Santoro A.; Puntoriero F.; Bonaccorsi P. M. BODIPY on board of sugars: a short enlightened journey up to the cells. ChemPhotoChem 2020, 4, 647–658. 10.1002/cptc.202000073. [DOI] [Google Scholar]
  12. a Liu B.; Novikova N.; Simpson M. C.; Timmer M. S. M.; Stocker B. L.; Söhnel T.; Ware D. C.; Brothers P. J. Lighting up sugars: fluorescent BODIPY–glucofuranose and – septanose conjugates linked by direct B–O–C bonds. Org. Biomol. Chem. 2016, 14, 5205–5209. 10.1039/C6OB00726K. [DOI] [PubMed] [Google Scholar]; b Nguyen A. L.; Griffin K. E.; Zhou Z.; Fronczek F. R.; Smith K. M.; Vicente M. G. H. Syntheses of 1,2,3-triazole-BODIPYs bearing up to three carbohydrate units. New J. Chem. 2018, 42, 8241–8246. 10.1039/C8NJ00041G. [DOI] [Google Scholar]
  13. Selected reviews of CuAAC cycloaddition:; a Mamidyala S. K.; Finn M. G. In situ click chemistry: probing the binding landscapes of biological molecules. Chem. Soc. Rev. 2010, 39, 1252–1261. 10.1039/b901969n. [DOI] [PubMed] [Google Scholar]; b Agnew H. D.; Rohde R. D.; Millward S. W.; Nag A.; Yeo W.-S.; Hein J. E.; Pitram S. M.; Tariq A. A.; Burns V. M.; Krom R. J.; Fokin V. V.; Sharpless K. B.; Heath J. R. Iterative in situ click chemistry creates antibody-like protein-capture agents. Angew. Chem., Int. Ed. 2009, 48, 4944–4948. 10.1002/anie.200900488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. a Boons G.-J. Strategies in oligosaccharide synthesis. Tetrahedron 1996, 52, 1095–1121. 10.1016/0040-4020(95)00897-7. [DOI] [Google Scholar]; b Galonic D. P.; Gin D. Y. Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines. Nature 2007, 446, 1000–1007. 10.1038/nature05813. [DOI] [PMC free article] [PubMed] [Google Scholar]; c Zhu X.; Schmidt R. R. New principles for glycoside-bond formation. Angew. Chem., Int. Ed. 2009, 48, 1900–1934. 10.1002/anie.200802036. [DOI] [PubMed] [Google Scholar]; d Demchenko A. V., Ed. Handbook of Chemical Glycosylation: Advances in Stereoselectivity and Therapeutic Relevance; Wiley-VCH: Weinheim, Germany, 2008. [Google Scholar]
  15. a Shivran N.; Tyagi M.; Mula S.; Gupta P.; Saha B.; Patro B. S.; Chattopadhyay S. Syntheses and photodynamic activity of some glucose-conjugated BODIPY-dyes. Eur. J. Med. Chem. 2016, 122, 352–365. 10.1016/j.ejmech.2016.06.050. [DOI] [PubMed] [Google Scholar]; b del Río M.; Lobo F.; Lopez J. C.; Oliden A.; Bañuelos J.; Lopez-Arbeloa I.; Garcia-Moreno I.; Gomez A. M. One-pot synthesis of rotationally restricted, conjugatable, BODIPY derivatives from phthalides. J. Org. Chem. 2017, 82, 1240–1247. 10.1021/acs.joc.6b02426. [DOI] [PubMed] [Google Scholar]; c Kesavan P. E.; Pandey V.; Raza M. K.; Mori S.; Gupta I. Water soluble thioglycosylated BODIPYs for mithochondria targeted cytotoxicity. Bioorg. Chem. 2019, 91, 103139. 10.1016/j.bioorg.2019.103139. [DOI] [PubMed] [Google Scholar]; d Uriel C.; Permingeat C.; Ventura J.; Avellanal-Zaballa E.; Bañuelos J.; Garcia-Moreno I.; Gomez A. M.; Lopez J. C. BODIPYs as chemically stable fluorescent tags for synthetic glycosylation strategies towards fluorescently labeled saccharides. Chem. - Eur. J. 2020, 26, 5388–5399. 10.1002/chem.201905780. [DOI] [PubMed] [Google Scholar]
  16. Yang Y.; Yu B. Recent advances in the chemical synthesis of C-glycosides. Chem. Rev. 2017, 117, 12281–12356. 10.1021/acs.chemrev.7b00234. [DOI] [PubMed] [Google Scholar]
  17. a Ferrier R. J.; Hoberg J. O. Synthesis and reactions of unsaturated sugars. Adv. Carbohydr. Chem. Biochem. 2003, 58, 55–119. 10.1016/S0065-2318(03)58003-9. [DOI] [PubMed] [Google Scholar]; b Ferrier R. J.; Zubkov O. A. Transformations of glycals into 2,3-unsaturated glycosyl derivatives. Org. React. 2003, 62, 569–736. 10.1002/0471264180.or062.04. [DOI] [Google Scholar]; c Gomez A. M.; Lobo F.; Uriel C.; Lopez J. C. Recent developments in the Ferrier rearrangement. Eur. J. Org. Chem. 2013, 2013, 7221–7262. 10.1002/ejoc.201300798. [DOI] [Google Scholar]; d Ansari A. A.; Lahiri R.; Vankar Y. D. The carbon-Ferrier rearrangement: an approach towards the synthesis of C-glycosides. ARKIVOC 2013, 2013, 316–362. 10.3998/ark.5550190.0014.223. [DOI] [Google Scholar]; e Gomez A. M.; Miranda S.; Lopez J. C. Ferrier rearranagement: an update on recent developments. Carbohydr. Chem. 2016, 42, 210–247. 10.1039/9781782626657-00210. [DOI] [Google Scholar]
  18. Two very recent manuscripts dealing with the structure of the “Ferrier glycosyl cation” have appeared:; a Bhuma N.; Lebedel L.; Yamashita H.; Shimizu Y.; Abada Z.; Arda A.; Desire J.; Michelet B.; Martin-Mingot A.; Abou-Hassan A.; Takumi M.; Marrot J.; Jimenez-Barbero J.; Nagaki A.; Bleriot Y.; Thibaudeau S. Insight into the Ferrier rearrangement by combining flash chemistry and superacids. Angew. Chem., Int. Ed. 2021, 60, 2036–2041. 10.1002/anie.202010175. [DOI] [PubMed] [Google Scholar]; b Greis K.; Kirschbaum C.; Leichnitz S.; Gewinner S.; Schöllkopf W.; von Helden G.; Meijer G.; Seeberger P. H.; Pagel K. Direct experimental characterization of the Ferrier glycosyl cation in the gas phase. Org. Lett. 2020, 22, 8916–8919. 10.1021/acs.orglett.0c03301. [DOI] [PubMed] [Google Scholar]; In the former manuscript, an allyloxycarbenium ion, i.e., a 1,2-unsaturated cation that is resonance-stabilized within the pyranose ring, e.g., 5 (Figure 2), was identified as the intermediate ionic species, whereas in the latter, a cation that is stabilized by the anchimeric assistance of the C4 neighboring acetyl group was presented. In any event, and pertinent to this work (regardless of the structure of the intermediate), the Ferrier cation is a stabilized, less encumbered, ion than a classical glycosyl cation.
  19. For literature precedents in the β-glycosylation of pyrrole by glycals, see:; Yadav J. S.; Reddy B. V. S.; Raman J. V.; Niranjan N.; kIRAN Kumar S.; Kunwar A. C. InCl3-catalyzed stereoselective synthesis of C-glycosyl heteroaromatics. Tetrahedron Lett. 2002, 43, 2095–2098. 10.1016/S0040-4039(02)00187-9. [DOI] [Google Scholar]
  20. The β-configurational assignment at the anomeric, C1′ and C1″, carbons was initially based on their 1H NMR coupling constants, which were in agreement with those for unsaturated aryl β-C-glycosides described by Sinou and co-workers:; Brakta M.; Lhoste P.; Sinou D. Palladium (0)-based approach to functionalized C-glycopyranosides. J. Org. Chem. 1989, 54, 1890–1896. 10.1021/jo00269a026. [DOI] [Google Scholar]
  21. The rigorous proof of the C1′ and C1″ configurations on the carbohydrate moieties was subsequently achieved by hydrogenation of compound 13, leading to a BODIPY with grafted saturated pyranoses. In this new derivative (see the Supporting Information for details), the observed coupling constants for the anomeric protons [1H NMR (300 MHz, CDCl3) δ 4.39 (dd, J1,2 = 11.6, 2.5 Hz, 2H)] were diagnostic for the β-orientation of the BODIPY substituent at the anomeric position of the carbohydrate.
  22. Lopez J. C.; del Rio M.; Oliden A.; Bañuelos J.; Lopez-Arbeloa I.; Garcia-Moreno I.; Gomez A. M. Solvent-sensitive emitting urea-bridged bis-BODIPYs: ready access by a one-pot tándem Staudinger/aza-Wittig ureation. Chem. - Eur. J. 2017, 23, 17511–17520. 10.1002/chem.201703383. [DOI] [PubMed] [Google Scholar]
  23. a Roacho R. I.; Metta-Magaña A. J.; Peña-Cabrera E.; Pannell K. H. Synthesis, structural characterization, and spectroscopic properties of the ortho, meta, and para isomers of 8-(CH2-C6H4)-BODIPY and 8-(MeOC6H4)-BODIPY. J. Phys. Org. Chem. 2013, 26, 345–351. 10.1002/poc.3095. [DOI] [Google Scholar]; b Lin Z.; Kohn A. W.; Van Voorhis T. Toward prediction of nonradiative decay pathways in organic compounds II: two internal conversion channels in BODIPYs. J. Phys. Chem. C 2020, 124, 3925–3938. 10.1021/acs.jpcc.9b08292. [DOI] [Google Scholar]
  24. Oliden-Sánchez A.; Sola-Llano R.; Bañuelos J.; Garcia-Moreno I.; Uriel C.; Lopez J. C.; Gomez A. M. Tuning the photonic behavior of symmetrical bis-BODIPY architectures: the key role of the spacer moiety. Front. Chem. 2019, 7, 801. 10.3389/fchem.2019.00801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Thakare S.; Stachelek P.; Mula S.; More A. B.; Chattopadhyay S.; Ray A. K.; Sekar R.; Ziessel A.; Harriman A. Harriman, Solvent-driven conformational exchange for amide-linked bichromophoric BODIPY derivatives. Chem. - Eur. J. 2016, 22, 14356–14366. 10.1002/chem.201602354. [DOI] [PubMed] [Google Scholar]
  26. Agazzi M. L.; Ballatore M. B.; Durantini A. M.; Durantini E. N.; Tomé A. C. BODIPYs in antitumoral and antimicrobial photodynamic therapy: an integrating review. J. Photochem. Photobiol., C 2019, 40, 21–48. 10.1016/j.jphotochemrev.2019.04.001. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

jo1c00413_si_001.pdf (3.1MB, pdf)

Articles from The Journal of Organic Chemistry are provided here courtesy of American Chemical Society

RESOURCES